On June 17, 2025, Kezar Life Sciences held its annual stockholders' meeting, electing three board members and approving executive compensation, with key votes including 2,151,745 in favor of the compensation. Independent auditors KPMG LLP were also ratified for 2025 with 6,116,820 votes for their selection.